Some individuals experience limited success with existing therapies
Regarding cardiovascular and renal effects, the two drug classes appear to work additively: SGLT2is primarily exert their cardiovascular benefits through hemodynamic effects, while GLP-1RAs mainly work through anti-atherogenic and anti-inflammatory actions 26
Care is designed to be safe, effective, and results-driven
It was initially developed for the treatment of type 2 diabetes mellitus, as it helps improve glycemic control by reducing glucose levels and regulating insulin secretion
While originally designed for Type 2 diabetes, GLP-1 drugs are now used for obesity, PCOS, cardiovascular protection, liver disease, and even neurological disorders
With the recent FDA approval of an oral Wegovy pill marking an important shift in the GLP-1 landscape, Dr